Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

This publication has 31 references indexed in Scilit:

• Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells
  Clinical Immunology, 2004
• A Protective Role of Locally Administered Immunostimulatory CpG Oligodeoxynucleotide in a Mouse Model of Genital Herpes Infection
  Journal of Virology, 2003
• Detoxification of Cholera Toxin without Removal of Its Immunoadjuvanticity by the Addition of (STa-related) Peptides to the Catalytic Subunit
  Journal of Biological Chemistry, 2002
• CpG Motifs in Bacterial DNA and Their Immune Effects
  Annual Review of Immunology, 2002
• Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-β-secreting cells and suppressing chemokine expression
  International Immunology, 2000
• Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice
  Clinical & Experimental Allergy, 2000
• A plant-based cholera toxin B subunit–insulin fusion protein protects against the development of autoimmune diabetes
  Nature Biotechnology, 1998
• Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin
  Vaccine, 1997
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 ⁺ T Cells
  Science, 1995
• Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems
  Vaccine, 1993